Bone marrow-derived mesenchymal stem cells in the treatment of myocardial infarction / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 108-112, 2015.
Article
in En
| WPRIM
| ID: wpr-257673
Responsible library:
WPRO
ABSTRACT
Bone marrow-derived mesenchymal stem cells (BMSCs) have the ability to regenerate myocadial tissue. BMSCs transplantation can produce cardiac-like cells,promote angiogenesis, and secrete a variety of growth factors and cytokines. This article summarizes the molecular mechanisms of myocardial repair, explores the potential regenerative capacity of cardiac muscles after myocardial infarction,and reviews the previous studies on BMSC transplantation for treatment of cardiac muscle after myocardial infarction, with an attempt to provide new insights in clinical decision-making.
Full text:
1
Database:
WPRIM
Main subject:
Wound Healing
/
Bone Marrow
/
Cytokines
/
Mesenchymal Stem Cells
/
Heart
/
Myocardial Infarction
/
Myocardium
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Acta Academiae Medicinae Sinicae
Year:
2015
Document type:
Article